Skip to content
Arine logo — Ensuring each patient is on the safest, most effective thera...

Arine

Ensuring each patient is on the safest, most effective therapy for their unique health needs

Founded 2017 United States San Francisco, United States 201 employees Series B Total: $40.00M Biotechnology, Health Care +1

General Information

Company Name Arine
Founded Year 2017
Location United States San Francisco, United States
Founders / Decision Makers
Team member
Employees 201
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Series B
Social

BounceWatch is an independent company data service, not affiliated with Arine. To contact Arine, visit arine.io.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Arine compare?

A PDF of Arine and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Arine soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Arine

Arine is a biotechnology and healthcare startup based in the United States. Founded in 2017, the company aims to optimize medication therapy and treatment plans, saving one in every six healthcare dollars spent. Using predictive analytics, AI, and machine learning, Arine's medication optimization platform aggregates and analyzes clinical, social, and behavioral data to identify and address gaps in patient care on behalf of payors and risk-bearing providers. The company has achieved significant results for its clients, including a 15% reduction in total cost of care and a 40% reduction in hospital admissions. Moreover, Arine has demonstrated the ability to improve the efficiency of the care team by five- to ten-fold. The recent Debt Financing investment on 17 August 2022 reflects the market's confidence in Arine's innovative approach to healthcare. The absence of specific investors in the latest round suggests that the company may have secured funding through alternative sources or efforts. With its compelling value proposition and positive impact on healthcare economics, Arine presents an intriguing opportunity for venture capital firms seeking investments in the biotechnology and healthcare sectors.

Business keywords: Medication Optimization, Healthcare Analytics, Predictive Analytics, AI in Healthcare, Clinical Data Analysis, Cost Reduction, Patient Care, Healthcare Efficiency, Personalized Care Plans, Healthcare Cost Savings, Data Aggregation, Treatment Plans

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing Undisclosed -
17 Aug 2022
Series B $29.00M 5
Katalyst Ventures, New Leaf Venture Partners +3
17 Aug 2022
Series A $11.00M 4
Katalyst Ventures, 111 West +2
11 Jan 2021
Series A Undisclosed 1
Katalyst Ventures
04 Oct 2019
Series A Undisclosed -
15 May 2019

Arine Alternatives & Competitors

View All Alternatives
Arine vs

Somos un ecosistema de tecnologías que impacta e innova la prestación de los servicios de salud y bi...

118 employees
AI, Biotechnology
Arine vs
Renalytix
Renalytix United States

Transforming kidney disease care with one simple blood test.

IPO
54 employees
AI, Biotechnology
Arine vs
hc1
hc1 United States

Healthcare Progress Starts Here®

Venture round
312 employees
Biotechnology, Computing

FAQ About Arine

Ensuring each patient is on the safest, most effective therapy for their unique health needs
Arine was founded in 2017.
Arine is headquartered in San Francisco, United States.
Arine operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on Medication Optimization, Healthcare Analytics, Predictive Analytics and AI in Healthcare.
Arine has approximately 201 employees.
Arine has completed 5 funding rounds, raising a total of $40.00M. The latest funding stage is Series B.
Top alternatives and competitors to Arine include Indigo Technologies LATAM, Renalytix, hc1, AlixaRx, CPS. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Arine and Indigo Technologies LATAM are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Arine, https://bouncewatch.com/company/arine, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout